| Pharmaceutical active ingredients: |
| Sumatriptan Succinate |
| Available forms, composition and doses of Imitrex: |
| Injectable; Injection; Sumatriptan Succinate 12 mg / mlSpray; Nasal; Sumatriptan Succinate 10 mg / doseSpray; Nasal; Sumatriptan Succinate 20 mg / doseSpray; Nasal; Sumatriptan Succinate 5 mg / doseTablets; Oral; Sumatriptan Succinate 100 mgTablets; Oral; Sumatriptan Succinate 25 mgTablets; Oral; Sumatriptan Succinate 50 mg |
| Imitrex medical category: |
| Human:Antimigraine preparationsSelective serotonin agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CC01 - Sumatriptan |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Imitrex: |
| Imitrex injection prescribing information (PDF)Imitrex nasal spray prescribing information (PDF)Imitrex tablets prescribing information (PDF) |